We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Adaptive Clinical Trials Initiative Lacks Clear Definition
The FDA faces an initial obstacle in its new effort to promote adaptive clinical trials: a lack of industry consensus as to what these trials entail, industry officials say.